We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
-5.3%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.6B
AUM Growth
-$635M
(-3.5%)
Cap. Flow
+$704M
Cap. Flow
% of AUM
3.99%
Top 10 Holdings %
Top 10 Hldgs %
10.79%
Holding
1,844
New
313
Increased
602
Reduced
402
Closed
527
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$317M |
| 2 |
Meta Platforms (Facebook)
META
|
+$204M |
| 3 |
Comcast
CMCSA
|
+$169M |
| 4 |
Goldman Sachs
GS
|
+$153M |
| 5 |
Apple
AAPL
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$404M |
| 2 |
Citigroup
C
|
+$158M |
| 3 |
Microsoft
MSFT
|
+$138M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 5 |
Union Pacific
UNP
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.78% |
| 2 | Financials | 14.08% |
| 3 | Consumer Discretionary | 12.95% |
| 4 | Industrials | 10.64% |
| 5 | Healthcare | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
926
DELISTED
Aerie Pharmaceuticals
AERI
| $2.13M | 0.01% |
234,625
-102,208
| -30% | -$788K |
|
927
S&P Global
SPGI
$124B
| $2.13M | 0.01% |
5,200
-127,571
| -96% | -$52M |
|
928
Patrick Industries
PATK
$2.79B
| $2.13M | 0.01% |
52,949
+7,742
| +17% | +$357K |
|
929
Madison Square Garden
MSGS
$9.93B
| $2.13M | 0.01% |
+11,860
| New | +$2.02M |
|
930
Carlisle Companies
CSL
$15.1B
| $2.13M | 0.01% |
8,642
+2,571
| +42% | +$603K |
|
931
Algonquin Power & Utilities
AQN
$4.46B
| $2.12M | 0.01% |
136,497
+48,865
| +56% | +$705K |
|
932
Bank OZK
OZK
$5.69B
| $2.11M | 0.01% |
49,346
+38,783
| +367% | +$1.81M |
|
933
Syndax Pharmaceuticals
SNDX
$1.72B
| $2.1M | 0.01% |
121,031
+107,202
| +775% | +$1.81M |
|
934
Group 1 Automotive
GPI
$3.14B
| $2.09M | 0.01% |
12,442
+6,654
| +115% | +$1.21M |
|
|
NAPA
935
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $2.08M | 0.01% |
114,099
-26,231
| -19% | -$512K |
|
936
BioCryst Pharmaceuticals
BCRX
$2.49B
| $2.07M | 0.01% |
127,510
-566,320
| -82% | -$9.08M |
|
|
Y
937
DELISTED
Alleghany Corp
Y
| $2.07M | 0.01% |
2,447
-13,307
| -84% | -$9.22M |
|
938
Churchill Downs
CHDN
$6.21B
| $2.06M | 0.01% |
+18,538
| New | +$2.04M |
|
939
Southwest Gas
SWX
$6.67B
| $2.05M | 0.01% |
+26,168
| New | +$1.83M |
|
|
GBT
940
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.05M | 0.01% |
59,113
-136,253
| -70% | -$4.07M |
|
941
Associated Banc-Corp
ASB
$6.07B
| $2.04M | 0.01% |
89,433
+79,762
| +825% | +$1.93M |
|
942
Fresenius Medical Care
FMS
$12.6B
| $2.03M | 0.01% |
60,366
+38,676
| +178% | +$1.27M |
|
943
SelectQuote
SLQT
$130M
| $2.03M | 0.01% |
726,358
+21,469
| +3% | +$103K |
|
944
Walker & Dunlop
WD
$1.46B
| $2.02M | 0.01% |
15,629
-11,951
| -43% | -$1.64M |
|
945
Pebblebrook Hotel Trust
PEB
$2.05B
| $2.01M | 0.01% |
+82,105
| New | +$1.89M |
|
946
Sabesp
SBS
$16.5B
| $2.01M | 0.01% |
1,054,091
+638,321
| +154% | +$939K |
|
947
Upland Software
UPLD
$18M
| $2.01M | 0.01% |
11,401
-1,368
| -11% | -$251K |
|
948
On Holding
ONON
$10.4B
| $2M | 0.01% |
+79,118
| New | +$2.11M |
|
949
Healthpeak Properties
DOC
$14.4B
| $2M | 0.01% |
58,146
-66,454
| -53% | -$2.24M |
|
950
Organogenesis Holdings
ORGO
$233M
| $1.99M | 0.01% |
261,330
+109,396
| +72% | +$847K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, Voloridge Investment Management held 1,844 positions worth $17.6B, down 3.5% from $18.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Voloridge Investment Management deployed $704M of net new capital in Q1 2022, opening 313 new positions and adding to 602 existing holdings. Its largest new stake was Meta Platforms (Facebook): 815,384 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Linde, an estimated $89M trimmed.
- Voloridge Investment Management's largest Q1 2022 buy was Meta Platforms (Facebook): 815,384 shares worth $181M.
- Voloridge Investment Management added most to PayPal in Q1 2022, an estimated $317M increase.
- Voloridge Investment Management's biggest Q1 2022 reduction was Linde, cutting an estimated $89M.
- Voloridge Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $404M.
- Voloridge Investment Management's ten largest holdings make up 11% of its $17.6B portfolio in Q1 2022.
- Voloridge Investment Management opened 313 new positions and closed 527 in Q1 2022.
- Voloridge Investment Management's portfolio value fell 3.5% quarter-over-quarter to $17.6B.
Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.